Different kinetics in anti-cytomegalovirus immunity reconstitution evaluated by lymphocyte proliferation and IFN-γ production in allogeneic and autologous bone marrow transplantation

Acta Haematologica

Volumn 107, Issue 4, 2002, Pages 187-194

  Mendes, A V A ^a,c   Benard, G ^b   Pereira, C B ^b   Kallas, E G ^b   Duarte, A J S ^b   Pannuti, C S ^a   Dulley, F L ^b   Machado, C M ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Bone marrow transplantation; CD8; Cytomegalovirus; IFN ; Immune reconstitution; Lymphoproliferative response

Indexed keywords

ACICLOVIR; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; ETOPOSIDE; GANCICLOVIR; MELPHALAN; THIOTEPA;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; INFECTION RISK; INTERFERON PRODUCTION; LEUKEMIA; LYMPHOCYTE PROLIFERATION; MALE; MORBIDITY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE; VIRUS DETECTION; VIRUS IMMUNITY; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTIGENS, VIRAL; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOCOMPETENCE; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASMS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; VIREMIA; VIRUS ACTIVATION;

EID: 0036281537     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058313     Document Type: Article

References (39)

1. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants
2. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation
3. Cytomegalovirus pp65 antigenemia guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study
4. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation
5. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus infection and disease
6. Cytomegalovirus infections in transplant patients
7. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants
8. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: Relationship between peak virus load, donor/recipient serostatus, acute GvHD and CMV disease
9. Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: No need for surveillance
10. Cytotoxic T cells in cytomegalovirus infection
11. Pathogenicity: Animal models
12. Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus
13. Increased adherence of CD2 peripheral blood lymphocytes to cytomegalovirus-infected fibroblasts is blocked by anti-LFA-3 antibody
14. Up-regulation of LFA-3 and ICAM-1 on the surface of fibro-blasts infected with cytomegalovirus
15. Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients
16. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis
17. Cytomegalovirus-specific lymphocyte proliferation and in vitro cytomegalovirus IgG synthesis for diagnosis of cytomegalovirus infections after bone marrow transplantation
18. Cytomegalovirus viraemia and specific T-helper cell responses as predictor of disease after allogeneic marrow transplantation
19. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease
20. Comparison of interleukin-2 and gamma-interferon production by peripheral blood mononuclear cells in response to cytomegalovirus after marrow transplantation
21. Bone marrow transplantation. Part 2
22. Cytomegalovirus antigenemia in acquired immunodeficiency syndrome patients with untreated cytomegalovirus retinitis
23. Cytomegalovirus pneumonia in allogenic BMT recipients undergoing early treatment or preemptive ganciclovir therapy
24. Workshop on CMV Disease; definitions, clinical severity scores and new syndromes
25. Immunosuppression in paracoccidioidomycosis: T cell hyporesponsiveness to two Paracoccidioides brasiliensis glycoproteins that elicit strong humoral immune response
26. Cytomegalovirus-specific IFN-gamma and IL-4 are produced by antigen expanded human blood lymphocytes from seropositive volunteers
27. Imbalance of IL-2, IFN-γ and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis
28. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation
29. Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients. A one year follow-up
30. Human cytomegalovirus-specific cytotoxic T lymphocytes: Requirements for in vitro generation and specificity
31. Infectious complications of human bone marrow transplantation
32. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation
33. Recovery of T cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft
34. Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation
35. Induction of bystander T cell proliferation by viruses and type I interferon in vivo
36. The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells
37. Gamma-IFN expression in CD8+ T cells is a maker for circulating cytotoxic T lymphocytes that recognize an HLA-A2 restricted epitope of human cytomegalovirus phosphoprotein pp65
38. Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant
39. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation